Tarsons Products Ltd — Q1 FY27 earnings call
Summary generated by AI from the official transcript Tarsons Products Ltd filed with BSE on 17 Aug 2026. Every statement cites a verbatim quote from that document — open any citation to read it. This is a record of what management said, not a recommendation. How we check these summaries
The short read
Tarsons reported consolidated revenue of Rs 110 crores in Q1 FY27, up around 21% year-on-year, with standalone revenue of Rs 86 crores also growing 21% and marking the company's highest ever Q1 standalone revenue. Management said domestic sales grew 17% and exports grew 29%, while gross and EBITDA margins were impacted by a sharp rise in raw material costs and higher costs from newly commissioned facilities. Management described the Panchla and Amta capacity expansion as nearing completion, with remaining lines expected to be commissioned in Q2 FY27 and fuller revenue contribution expected from FY28 onwards.
Numbers mentioned
Consolidated revenue: Rs. 110 crores (Q1 FY27)
p. 3
“we delivered a healthy performance in Q1 FY’27 with consolidated revenue of Rs. 110 crores, growing by almost 21% Y-o-Y.”
Aryan Sehgal, page 3 of the filed PDF · View the filing
Standalone revenue: Rs. 86 crores (Q1 FY27)
p. 3
“Our standalone revenue also grew by 21% Y-o-Y and came to Rs. 86 crores, marking our highest ever Q1 standalone revenue.”
Aryan Sehgal, page 3 of the filed PDF · View the filing
Domestic sales growth: 17% (Q1 FY27)
p. 3
“Our domestic sales grew 17% Y-o-Y, supported by the strength of our extensive distribution network, deeper customer engagement and improving demand conditions.”
Aryan Sehgal, page 3 of the filed PDF · View the filing
Export growth: 29% (Q1 FY27)
p. 4
“our export business from India saw a healthy recovery, growing 29% in the first quarter.”
Aryan Sehgal, page 4 of the filed PDF · View the filing
Nerbe (German subsidiary) revenue growth: approximately 6% year-on-year in constant currency terms (Q1 FY27)
p. 4
“our German-based subsidiary delivered a resilient performance, with revenue growing approximately 6% year-on-year in constant currency terms.”
Aryan Sehgal, page 4 of the filed PDF · View the filing
Consolidated cash profit: INR 25.6 crores (Q1 FY27)
p. 5
“This is reflected in the steady improvement in the cash profit, which has grown 18% year-on-year and stood at INR 25.6 crores on a consolidated basis.”
Aryan Sehgal, page 5 of the filed PDF · View the filing
Standalone revenue: INR 86.1 crores (Q1 FY27)
p. 6
“Revenue for Q1 FY’27 stood at INR 86.1 crores compared to INR 71.3 crores in Q1 FY’26, registering a growth of almost 21% on a year-on-year basis.”
Santosh Agarwal, page 6 of the filed PDF · View the filing
Standalone gross margin: 67.1% (Q1 FY27)
p. 6
“Gross margin for the standalone business in Q1 FY’27 stood at 67.1%, impacted by higher raw material costs arising from the spike in polymer prices.”
Santosh Agarwal, page 6 of the filed PDF · View the filing
Standalone EBITDA: INR 24.2 crores (Q1 FY27)
p. 6
“EBITDA for Q1 FY’27 stood at INR 24.2 crores.”
Santosh Agarwal, page 6 of the filed PDF · View the filing
Standalone cash profitability: INR 25.2 crores (Q1 FY27)
p. 6
“Cash profitability for the quarter stood at INR 25.2 crores, showing a healthy growth of 18% on a Y-o-Y basis.”
Santosh Agarwal, page 6 of the filed PDF · View the filing
Consolidated revenue: INR 110.2 crores (Q1 FY27)
p. 6
“Speaking about the consolidated performance, consolidated revenue for Q1 FY’27 stood at INR 110.2 crores, registering a strong growth of 20.7% Y-o-Y basis.”
Santosh Agarwal, page 6 of the filed PDF · View the filing
Consolidated EBITDA and margin: INR 26 crores, 23.6% (Q1 FY27)
p. 6
“Consolidated EBITDA in Q1 FY’27 stood at INR 26 crores, with the EBITDA margin at 23.6%.”
Santosh Agarwal, page 6 of the filed PDF · View the filing
Gross debt: INR 380 crores (as of Q1 FY27)
p. 9
“The gross debt for the company is about to be INR 380 crores, and the net debt is about to be INR 330-340 crores, something like that.”
Santosh Agarwal, page 9 of the filed PDF · View the filing
Standalone depreciation: INR 24.5 crores (Q1 FY27)
p. 9
“this year our depreciation on standalone basis is INR 24.5 crores.”
Santosh Agarwal, page 9 of the filed PDF · View the filing
Capital work in progress: INR 160 crores (as of Q1 FY27)
p. 9
“we have INR 160 crores of capital work in progress, which we think that, that will be capitalized and moved to main capital asset segment in the subsequent quarter.”
Santosh Agarwal, page 9 of the filed PDF · View the filing
What management said it would do
A record of statements made on the call, in the words management used. Parakho does not forecast, endorse or assess them, and their presence here is not a view on whether they will happen.
Full-year depreciation — approximately INR 105 crores to INR 110 crores · FY27
stated firmly by Santosh Agarwal
p. 9
“we believe that in the full year, the depreciation will be in the range of approximately INR 105 crores to INR 110 crores. That would be the peak year for our depreciation.”
Santosh Agarwal, page 9 of the filed PDF · View the filing
Net debt reduction — INR 40 crores to INR 50 crores · this year
stated conditionally by Santosh Agarwal
p. 9
“we believe that INR 40 crores to INR 50 crores rupees of debt should be reduced year-on-year basis.”
Santosh Agarwal, page 9 of the filed PDF · View the filing
Interest cost run rate — about INR 20 crores per year · FY27
stated firmly by Santosh Agarwal
p. 12
“Sir, our current run rate is about to be INR 20 crores per year. And we believe that the same rate will continue in FY’27 also. But in FY’28, it will go down.”
Santosh Agarwal, page 12 of the filed PDF · View the filing
Remaining facility commissioning — fully commissioned · Q2 FY27
stated firmly by Aryan Sehgal
p. 5
“We expect these facilities to be fully commissioned during Q2, with revenue contribution beginning from second half.”
Aryan Sehgal, page 5 of the filed PDF · View the filing
Panchla and Amta contribution to standalone revenue — 20% to 25% of standalone revenues · FY28
stated as an aspiration by Aryan Sehgal
p. 15
“We would ideally expect Panchla and Amta to at least contribute to 20% to 25% of our standalone revenues in FY’28.”
Aryan Sehgal, page 15 of the filed PDF · View the filing
Revenue from new product portfolio — approximately INR 65 crores to INR 70 crores · FY28
stated as an aspiration by Aryan Sehgal
p. 15
“we could expect from my entire portfolio of new products, approximately INR 65 crores to INR 70 crores in the next year is what we expect from our entire new portfolio.”
Aryan Sehgal, page 15 of the filed PDF · View the filing
Domestic market growth — late single digits
stated as an aspiration by Aryan Sehgal
p. 11
“I believe we are almost there to the late single digits where the domestic market traditionally grew at pre-COVID levels.”
Aryan Sehgal, page 11 of the filed PDF · View the filing
Revenue growth rate — 15% and above
stated as an aspiration by Aryan Sehgal
p. 12
“if you see our numbers pre-2021, which is pre-COVID, we have grown at a sustainable level of 15% and above every year.”
Aryan Sehgal, page 12 of the filed PDF · View the filing
Annual maintenance CAPEX — not more than INR 20-odd crores per year, possibly INR 25 crores in tough years
stated as an aspiration by Aryan Sehgal
p. 15
“we don’t expect to exceed that or more than INR 20-odd crores per year. Maybe in some tough years, it could be INR 25 crores.”
Aryan Sehgal, page 15 of the filed PDF · View the filing
CAPEX for the year — no major capex, only maintenance/required capex · FY27
stated firmly by Santosh Agarwal
p. 9
“There is no CAPEX plan as such. As we already said that some maintenance CAPEX and some required CAPEX will only be undertaken. Otherwise, there will not be any major CAPEX.”
Santosh Agarwal, page 9 of the filed PDF · View the filing
Peak incremental revenue from CAPEX plan — INR 750 crores to INR 800 crores
stated as an aspiration by Aryan Sehgal
p. 12
“I would say more like INR 750 crores, what I discussed in our calls earlier. INR 750 crores to INR 800 crores, not INR 900 crores. Yes.”
Aryan Sehgal, page 12 of the filed PDF · View the filing
Q&A highlights
Management's answers to analyst questions, in Parakho's words rather than a transcript. Each row names who answered and carries the verbatim quote it was drawn from.
Management attributed the delay to the scale of the project, dependence on external engineering teams and supplier-specific issues.
Answered by Aryan Sehgal
Asked by Jasdeep Walia: Why has Panchla commercial commissioning been delayed from the original FY27 start guidance?
p. 8
“It is just the sheer scale and size and the number of projects coming in at Panchla.”
Aryan Sehgal, page 8 of the filed PDF · View the filing
CFO gave current gross and net debt figures and said depreciation would peak this year before declining.
Answered by Santosh Agarwal
Asked by Jasdeep Walia: What is the gross and net debt, and have depreciation and interest costs peaked?
p. 9
“The gross debt for the company is about to be INR 380 crores, and the net debt is about to be INR 330-340 crores, something like that.”
Santosh Agarwal, page 9 of the filed PDF · View the filing
Management said input costs have been volatile, with almost no price hikes internationally and only marginal hikes domestically.
Answered by Aryan Sehgal
Asked by Aditya: How are raw material prices trending and what price hikes have been taken domestically and internationally?
p. 10
“The input costs were at its peak, maybe six weeks ago and then started dipping down with a peace agreement and other things in place.”
Aryan Sehgal, page 10 of the filed PDF · View the filing
Management estimated peak incremental revenue of roughly Rs 750-800 crore from the full four-year capex program.
Answered by Aryan Sehgal
Asked by Rahul Jain: What incremental revenue is possible once the pending capex is completed?
p. 12
“So, on a fixed asset basis, we should be able to turn in at around 0.8times. So, we are looking at somewhere around INR 400 crores of incremental revenue over and above what we have in our facilities existing through the entire 4-year CAPEX plan.”
Aryan Sehgal, page 12 of the filed PDF · View the filing
Management said growth beyond 15% depends on the success of new product lines like cell culture and on the international environment.
Answered by Aryan Sehgal
Asked by Kiran: What would it take for the company to grow beyond 15%?
p. 14
“there will be a lot of factors involved with how successfully our new products can be launched for these numbers.”
Aryan Sehgal, page 14 of the filed PDF · View the filing
Management said margins for the year currently look similar to Q1 but remain highly dependent on volatile input costs over the rest of the year.
Answered by Aryan Sehgal
Asked by Nishitha: What EBITDA margin can be expected for the full year FY27?
p. 14
“For now, it looks similar to what we have achieved in Q1. But if input costs, because see, it is a direct hit of about 4.5%, 5%, 500 basis points almost on the gross margin or the material margin.”
Aryan Sehgal, page 14 of the filed PDF · View the filing
Management confirmed a benefit from shipment timing and noted shipment nomination is outside their control, which could cause weaker quarters ahead.
Answered by Aryan Sehgal
Asked by Nikhil Upadhyay: Did export growth this quarter benefit from bunched-up shipments rather than normal run-rate sales?
p. 16
“there is a huge benefit of shipments as well because what happens is shipments are beyond our control.”
Aryan Sehgal, page 16 of the filed PDF · View the filing
Management said government business share has declined due to abolition of rate contracts and the shift to GEM portal bidding.
Answered by Aryan Sehgal
Asked by Aditya: What share of the domestic market comes from government institutions and has that share fallen?
p. 18
“Yes, I think our share in government business has gone down.”
Aryan Sehgal, page 18 of the filed PDF · View the filing
Risks flagged
Sharp escalation in raw material/input costs pressuring gross margins
p. 5
“Our key input costs have gone up anywhere in the range of 25% to 50%, putting pressure on gross margins.”
Aryan Sehgal, page 5 of the filed PDF · View the filing
Volatility and unpredictability of raw material prices
p. 10
“There is not much stability at this point of time in raw material prices.”
Aryan Sehgal, page 10 of the filed PDF · View the filing
Delay in commissioning of new capacity due to scale and supplier issues
p. 8
“different suppliers come up with different kinds of challenges and different operational issues which you have to resolve for, which is a very standard and normal part.”
Aryan Sehgal, page 8 of the filed PDF · View the filing
Shipment timing outside company control affecting quarterly export performance
p. 16
“many of our shipments are nominated by our buyers and not in our control.”
Aryan Sehgal, page 16 of the filed PDF · View the filing
Vessel and shipping availability constraints due to West Asia crisis
p. 16
“With the West Asia crisis, availability of vessels and ships is also not at the best situation.”
Aryan Sehgal, page 16 of the filed PDF · View the filing
Tariff-related uncertainty and rumors affecting export markets
p. 17
“It is challenging. The environment and market is challenging, specifically because of rumors of tariffs moving again on India, as well as input costs drastically increasing in India.”
Aryan Sehgal, page 17 of the filed PDF · View the filing
Intense Chinese competition in international markets
p. 9
“We do face intense Chinese competition internationally from Chinese players in different parts of the world, in Europe and U.S. and that intensity has not reduced.”
Aryan Sehgal, page 9 of the filed PDF · View the filing
Inability to pass on full input cost increases to customers due to competitive pricing environment
p. 10
“The pure reason for gross margin going down is higher input costs and higher purchase price of raw materials and inability to pass on the entire price increase to customers.”
Aryan Sehgal, page 10 of the filed PDF · View the filing
Loss of government rate contracts reducing institutional business
p. 18
“a lot of these research institutes have abolished rate contracts. And now they must move to a GEM bid every time they want to procure materials.”
Aryan Sehgal, page 18 of the filed PDF · View the filing
Generated by claude-sonnet-5. Source: the transcript as filed with BSE. We link to the exchange's copy; we do not host transcripts. Parakho is a data and screening tool, not an investment adviser — nothing here is a recommendation to buy, sell or hold.